XTL BIOPHARMACEUTICALS LTD. Interest Expense
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Interest Expense of $28.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Expense Statement
ifrs-full:InterestExpense · last filed 2025-04-30
| Period end | Interest Expense 12 month |
|---|---|
| 2024-12-31 | $28.00K 20-F · filed 2025-04-30 |